The National Institutes of Health is permanently closing one of two pharmacies that had issues with sterility processes, according to an article on The Wall Street Journal website.
The facilities received critical reports of their sterility processes a year ago from the Food and Drug Administration.
Both facilities are located in the NIH Clinical Center, which largely treats patients who are entered in clinical studies.
An FDA inspection in May 2015 found what the agency termed “significant violations of current good manufacturing practice” at the PDS, such as failing to thoroughly investigate discrepancies in drug batches.
The Role of Positive Distraction in Pediatric Design
Healthcare Waste is Fueling America's Debt
Prairie Lakes Healthcare System to Rebrand Following Sanford Health Merger
How Digital Technologies Are Reshaping Performance in Healthcare Facilities
The Role of Plumbing in Healthcare-Associated Infections